Ribosomal protein L22 pseudogene 6 (RPL22P6)

Ribosomal protein L22 pseudogene 6 (RPL22P6) is a processed pseudogene corresponding to the functional ribosomal protein L22 (RPL22) gene, which encodes a component of the 60S cytoplasmic ribosomal subunit essential for protein synthesis[2][3]. Like most ribosomal protein pseudogenes, RPL22P6 is the result of retrotranspositional insertion events and does not produce a functional protein product[2]. It is dispersed in the human genome among numerous other ribosomal protein pseudogenes, and there is no evidence it functions as a therapeutic target, molecular marker, or biomarker in disease[2][3]. Key supporting details: - Pseudogenes are non-functional segments of DNA resembling functional genes, often arising from retrotransposition and lacking coding potential due to disabling mutations[2]. - RPL22P6 is specifically identified as a pseudogene; not a functional protein and not implicated in disease or therapy[2]. - All available sources agree: RPL22P6 is not a therapeutic target; the functional counterpart is RPL22[1][2][3]. - No evidence links RPL22P6 to biological activity, disease, or drug interaction. Note: The entry is technically "incorrect" as a biological or therapeutic target since it is a pseudogene and not an active protein, receptor, enzyme, or similar entity. RPL22P6 should not be considered an actionable drug target or functional biomolecule[2][3].

Other names

RPL22_1_94RPL22P6